Neurotechnology
Paradromics
30-Second Executive Brief
Executive Assessment
Paradromics functions as a regional institution within Neurotechnology, backed by 47% sourcing coverage, with a stable competitive position.
- Maintains 3 mapped relationships across the graph
- 47% sourcing coverage across sourced relationships
- Tracked as regional institution within the Neurotechnology category
Executive Snapshot
- Strategic Role
- Regional Institution
- Sourcing Coverage
- 47%
- Ecosystem Influence
- Moderate
- Strategic Momentum
- Insufficient Data
View Methodology →
Computed live from this entity's own relationships and evidence: how many relationships carry at least one linked citation, weighted with citation recency and source type — independent of Strategic Importance, and not a prediction. Not a hand-typed number; recalculated on every read.
Coverage
- Mapped Relationships
- 3
- Technology Domains
- 4
Strategic Implications
- Central node connecting multiple strategic ecosystems
- Directly influences technology and capital flows
- Material relevance to downstream dependency mapping
Top Opportunities
Top Risks
Critical Dependencies
Developer of the Connexus brain-computer interface, a wireless implant designed to record and decode brain signals at the individual-neuron level to restore communication for patients with severe speech impairment. Neurosurgeons at University of Michigan Health completed the first-in-human implantation of the wireless Connexus BCI in 2026 as part of the multi-site Connect-One clinical study, following FDA approval of the study and Paradromics' acceptance into an FDA regulatory accelerator program with a new patient registry.
Sources
Every claim traced to a primary source — evidence, recent activity, and insider filing behavior, all in one place.
Evidence
2 sources
- BioSpace / Paradromics — Paradromics accepted into FDA regulatory accelerator program, adds third clinical trial sitecompany
- Michigan Medicine — University of Michigan implants first-in-human Paradromics wireless BCIinstitution
Acquisition & Investment Fit
AI-reasoned, generated only from entities already in InsightNodes's own graph — a hypothetical strategic-fit exercise, not real M&A intelligence or a signal that any deal is planned or in progress.
Relationship Map
The relationships surrounding Paradromics — ownership, dependencies, regulation, technology and market context. Click any node to make it the new center, 2 levels deep.
Connection type
Click any node to make it the new center. Scroll to zoom, drag to pan.
The Story So Far (last 6 months)
Auto-generated from this entity's dated milestones, relationship updates, and sourced evidence — not AI-written, just sorted.
Paradromics's Timeline
A sourced, dated history of Paradromics's key moments — founding to present.
Jan 2015 · Founded
Paradromics was founded to develop high-bandwidth, wireless brain-computer interfaces for restoring communication in patients with severe speech impairment.
Jan 2026 · First-in-human Connexus implant at University of Michigan
Neurosurgeons at University of Michigan Health completed the first-in-human implantation of Paradromics' wireless Connexus brain-computer interface, part of the national multi-site Connect-One clinical study following FDA approval.